Mealey's (July 23, 2018, 2:19 PM EDT) -- SEATTLE — A federal judge in Washington on July 20 granted final approval of a $3.5 million securities class action settlement between shareholders and a health care company and its CEO over the defendants’ alleged misrepresentations made with regard to the company’s breast cancer screening products, bringing an end to the action, which was originally filed in October 2013 (In re Atossa Genetics Inc. Securities Litigation, No. 13-1836, W.D. Wash., 2018 U.S. Dist. LEXIS 121864)....